Paper manufacturing
EGF II | EGF III

Invested In

2022

Divested In

Investment Rationale

Investment in a company that is essentially an exporter, which sustainably explores tissue paper solutions to improve people’s health and well-being.

Strategy

Support the development of pioneering solutions in the paper industry, focusing on the use of more sustainable raw materials and the creation of new high-quality finished products, which will allow the Company to continue on its growth trajectory, creating value and increasingly becoming a benchmark in the European tissue paper sector.